Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

G2019S LRRK2 Parkinson's Disease: Increasing Awareness and Genetic Testing Program

NCT04919356 is registered in ClinicalTrials.gov with Escape Bio, Inc. as lead sponsor.

NCT NCT04919356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04919356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
G2019S LRRK2 Parkinson's Disease: Increasing Awareness and Genetic Testing Program
Lead sponsor
Escape Bio, Inc.
Phase
Observational
Overall status
Terminated
Start date
June 8, 2021
Completion date
December 5, 2022
Enrollment
836 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease